Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis
Open accessAbstract
Hepatocellular carcinoma (HCC) is a devastating cancer increasingly caused by non-alcoholic fatty liver disease (NAFLD). Disrupting the liver Mitochondrial Pyruvate Carrier (MPC) in mice attenuates NAFLD. Thus, we considered whether liver MPC disruption also prevents HCC. Here, we use the N-nitrosodiethylamine plus carbon tetrachloride model of HCC development to test how liver-specific MPC knock out affects hepatocellular tumorigenesis. Our data show that liver MPC ablation markedly decreases tumorigenesis and that MPC-deficient tumors transcriptomically downregulate glutathione metabolism. We observe that MPC disruption and glutathione depletion in cultured hepatomas are synthetically lethal. Stable isotope tracing shows that hepatocyte MPC disruption reroutes glutamine from glutathione synthesis into the tricarboxylic acid (TCA) cycle. These results support a model where inducing metabolic competition for glutamine by MPC disruption impairs hepatocellular tumorigenesis by limiting glutathione synthesis. These findings raise the possibility that combining MPC disruption and glutathione stress may be therapeutically useful in HCC and additional cancers.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Experiments using uniformly labeled 13C-glutamine showed that glutathione was enriched with five 13C atoms, suggesting that glutamine is the major source of glutathione.
“Indeed, experiments using uniformly labeled 13C-glutamine showed that glutathione was enriched with five 13C atoms in glutathione, suggesting that glutamine is the major source of glutathione16,57,60.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 22,207 · see citing works
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works
Estes, C., Razavi, H. A., Loomba, R. S., Younossi, Z. M., & Sanyal, A. J. (2017) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,416 · see citing works
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119 · see citing works
Glutathione metabolism in cancer progression and treatment resistance
Bansal, A., & Simon, M. C. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201804161 · Cited by 1,234 · see citing works
Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993 · see citing works
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 856 · see citing works
Bricker, D. K., Taylor, E. B., Schell, J. C., Orsak, T., Boutron, A., Chen, Y.-C., Cox, J. E., Cardon, C. M., Van Vranken, J. G., Dephoure, N., et al. (2012) · Science · doi:10.1126/science.1218099 · Cited by 843 · see citing works
Self-citationYounossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802 · see citing works
Identification and Functional Expression of the Mitochondrial Pyruvate Carrier
Herzig, S., Raemy, E., Montessuit, S., Veuthey, J.-L., Zamboni, N., Westermann, B., Kunji, E. R. S., & Martinou, J.-C. (2012) · Science · doi:10.1126/science.1218530 · Cited by 747 · see citing works
Yang, C., Ko, B., Hensley, C. T., Jiang, L., Wasti, A. T., Kim, J., Sudderth, J., Calvaruso, M. A., Lumata, L., Mitsche, M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.025 · Cited by 679 · see citing works
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · see citing works
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603 · cited 13× · see citing works
“Thus, a critical question is whether the anti-NAFLD or pro-HCC metabolism effects of MPC disruption dominate to decrease or increase HCC development.”
InfluentialMetabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
Huang, Q., Tan, Y., Yin, P., Ye, G., Gao, P., Lu, X., Wang, H., & Xu, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0308 · Cited by 415 · see citing works
Satapati, S., Sunny, N. E., Kucejova, B., Fu, X., He, T. T., Méndez-Lucas, A., Shelton, J. M., Perales, J. C., Browning, J. D., & Burgess, S. C. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m023382 · Cited by 407 · see citing works
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Satapati, S., Kucejová, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K. A., Fu, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82204 · Cited by 400 · see citing works
Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism
Schell, J. C., Wisidagama, D. R., Bensard, C., Zhao, H., Wei, P., Tanner, J., Flores, A., Mohlman, J., Sorensen, L. K., Earl, C. S., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3593 · Cited by 322 · see citing works
Lactate dehydrogenase activity drives hair follicle stem cell activation
Flores, A., Schell, J., Krall, A. S., Jelinek, D., Miranda, M., Grigorian, M., Braas, D., White, A. C., Zhou, J. L., Graham, N. A., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3575 · Cited by 301 · see citing works
Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier
Vacanti, N. M., Divakaruni, A. S., Green, C. R., Parker, S. J., Henry, R. R., Ciaraldi, T. P., Murphy, A. N., & Metallo, C. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.024 · Cited by 277 · see citing works
The story of HCC in NAFLD : from epidemiology, across pathogenesis, to prevention and treatment
Margini, C., & Dufour, J. (2015) · Liver International · doi:10.1111/liv.13031 · Cited by 246 · see citing works
Gray, L. R., Sultana, M. R., Rauckhorst, A. J., Oonthonpan, L., Tompkins, S. C., Sharma, A., Fu, X., Miao, R., Pewa, A. D., Brown, K., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.027 · Cited by 217 · see citing works
Self-citationMcCommis, K. S., Chen, Z., Fu, X., McDonald, W. G., Colca, J. R., Kletzien, R. F., Burgess, S. C., & Finck, B. N. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.028 · Cited by 210 · see citing works
Bader, D. A., Hartig, S. M., Putluri, V., Foley, C., Hamilton, M. P., Smith, E. A., Saha, P., Panigrahi, A., Walker, C. M., Zong, L., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0002-y · Cited by 168 · see citing works
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
Ma, R., Zhang, W., Tang, K., Zhang, H., Zhang, Y., Li, D., Li, Y., Xu, P., Luo, S., Cai, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3508 · Cited by 163 · see citing works
Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
Divakaruni, A. S., Wallace, M., Buren, C., Martyniuk, K. M., Andreyev, A. Y., Li, E., Fields, J. A., Cordes, T., Reynolds, I. J., Bloodgood, B. L., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201612067 · Cited by 157 · see citing works
Uehara, T., Pogribny, I. P., & Rusyn, I. (2014) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1430s66 · Cited by 156 · see citing works
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Degasperi, E., & Colombo, M. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30018-8 · Cited by 155 · see citing works
Hirata, H., Sugimachi, K., Komatsu, H., Ueda, M., Masuda, T., Uchi, R., Sakimura, S., Nambara, S., Saito, T., Shinden, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2601 · Cited by 151 · see citing works
McCommis, K. S., Hodges, W. T., Brunt, E. M., Nalbantoglu, I., McDonald, W. G., Holley, C. L., Fujiwara, H., Schaffer, J. E., Colca, J. R., & Finck, B. N. (2016) · Hepatology · doi:10.1002/hep.29025 · Cited by 138 · see citing works
Hatem, E., Banna, N. E., & Huang, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 126 · see citing works
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
Kutlu, Ö., Kaleli, H. N., & Ozer, E. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/8543763 · Cited by 102 · see citing works
New Serum Markers of Hepatocellular Carcinoma
Masuzaki, R., Karp, S. J., & Omata, M. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.009 · Cited by 101 · see citing works
Loss of MPC1 reprograms retinal metabolism to impair visual function
Grenell, A., Wang, Y., Yam, M., Swarup, A., Dilan, T. L., Hauer, A., Linton, J. D., Philp, N. J., Gregor, E., Zhu, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812941116 · Cited by 101 · see citing works
Yan, Z., Yan, H., & Ou, H. (2012) · Gene · doi:10.1016/j.gene.2012.07.009 · Cited by 87 · see citing works
Pound, A. W., & McGuire, L. J. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.88 · Cited by 85 · see citing works
Rauckhorst, A. J., Gray, L. R., Sheldon, R. D., Fu, X., Pewa, A. D., Feddersen, C. R., Dupuy, A. J., Gibson-Corley, K. N., Cox, J. E., Burgess, S. C., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.09.002 · Cited by 74 · see citing works
Self-citationThe yeast mitochondrial pyruvate carrier is a hetero-dimer in its functional state
Tavoulari, S., Thangaratnarajah, C., Mavridou, V., Harbour, M. E., Martinou, J., & Kunji, E. R. (2019) · The EMBO Journal · doi:10.15252/embj.2018100785 · Cited by 73 · see citing works
Li, X., Han, G., Li, X., Kan, Q., Fan, Z., Li, Y., Ji, Y., Zhao, J., Zhang, M., Grigalavicius, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18199 · Cited by 71 · see citing works
mTORC2 controls cancer cell survival by modulating gluconeogenesis
Khan, M. W., Biswas, D., Ghosh, M., Mandloi, S., Chakrabarti, S., & Chakrabarti, P. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.16 · Cited by 70 · see citing works
Sharma, A., Oonthonpan, L., Sheldon, R. D., Rauckhorst, A. J., Zhu, Z., Tompkins, S. C., Cho, K., Grzesik, W. J., Gray, L. R., Scerbo, D. A., et al. (2019) · eLife · doi:10.7554/elife.45873 · Cited by 67 · see citing works
Self-citationLam, H. C., Baglini, C. V., Lope, A. L., Parkhitko, A. A., Liu, H.-J., Alesi, N., Malinowska, I. A., Ebrahimi‐Fakhari, D., Saffari, A., Yu, J. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2458 · Cited by 61 · see citing works
Clinical applications of urinary organic acids. Part I: Detoxification markers.
Lord, R. S., & Bralley, J. A. (2008) · PubMed · Cited by 60 · see citing works
MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis
Colca, J. R., McDonald, W. G., & Adams, W. J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1494153 · Cited by 49 · see citing works
Pajares, M. A., & Pérez‐Sala, D. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7237 · Cited by 48 · see citing works
Li, Y., Li, X., Kan, Q., Zhang, M., Li, X., Xu, R., Wang, J., Yu, D., Goscinski, M. A., Wen, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13717 · Cited by 41 · see citing works
Glutathione metabolism modeling: A mechanism for liver drug-robustness and a new biomarker strategy
Geenen, S., du Preez, F. B., Snoep, J. L., Foster, A. J., Sarda, S., Kenna, J. G., Wilson, I. D., & Westerhoff, H. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.014 · Cited by 39 · see citing works
Orrù, C., Szydlowska, M., Taguchi, K., Zavattari, P., Perra, A., Yamamoto, M. P., & Columbano, A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.010 · Cited by 38 · see citing works
Sandoval, I. T., Delacruz, R. G. C., Miller, B. N., Hill, S., Olson, K. A., Gabriel, A. E., Boyd, K. A., Satterfield, C., Remmen, H. V., Rutter, J. P., et al. (2017) · eLife · doi:10.7554/elife.22706 · Cited by 32 · see citing works
Oonthonpan, L., Rauckhorst, A. J., Gray, L. R., Boutron, A., & Taylor, E. B. (2019) · JCI Insight · doi:10.1172/jci.insight.126132 · Cited by 31 · see citing works
Self-citationShang, F., Liu, M., Li, B., Zhang, X., Sheng, Y., Liu, S., Han, J., Li, H., & Xiu, R. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3030-x · Cited by 29 · see citing works
Glutathione biosynthesis is upregulated at the initiation of MYCN‐driven neuroblastoma tumorigenesis
Carter, D. R., Sutton, S. K., Pajic, M., Murray, J. E., Sekyere, E. O., Fletcher, J. I., Beckers, A., Preter, K. D., Speleman, F., George, R. E., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.02.004 · Cited by 25 · see citing works
Prevention of Hepatocellular Carcinoma
Schütte, K., Balbisi, F., & Malfertheiner, P. (2016) · Gastrointestinal Tumors · doi:10.1159/000446680 · Cited by 22 · see citing works
Facciorusso, A., Villani, R., Bellanti, F., Mitarotonda, D., Vendemiale, G., & Serviddio, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160209153624 · Cited by 18 · see citing works
Likhitrattanapisal, S., Tipanee, J., & Janvilisri, T. (2016) · Tumor Biology · doi:10.1007/s13277-016-5186-8 · Cited by 17 · see citing works
Marrone, A. K., Shpyleva, S., Chappell, G. A., Tryndyak, V., Uehara, T., Tsuchiya, M., Beland, F. A., Rusyn, I., & Pogribny, I. P. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22323 · Cited by 13 · see citing works
Chappell, G. A., Silva, G. O., Uehara, T., Pogribny, I. P., & Rusyn, I. (2016) · Cancer Medicine · doi:10.1002/cam4.606 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works
Redox regulation of immunometabolism
Muri, J., & Köpf, M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00478-8 · Cited by 501 · see citing works
Changes in Glutathione Content in Liver Diseases: An Update
Vairetti, M., Pasqua, L. G. D., Cagna, M., Richelmi, P., Ferrigno, A., & Berardo, C. (2021) · Antioxidants · doi:10.3390/antiox10030364 · Cited by 323 · see citing works
The multifaceted pyruvate metabolism: role of the mitochondrial pyruvate carrier
Zangari, J., Petrelli, F., Maillot, B., & Martinou, J.-C. (2020) · Biomolecules · doi:10.3390/biom10071068 · Cited by 172 · see citing works
Tumour metabolism and its unique properties in prostate adenocarcinoma
Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 154 · see citing works
Glutathione Metabolism and the Novel Role of Mitochondrial GSH in Retinal Degeneration
Sreekumar, P. G., Ferrington, D. A., & Kannan, R. (2021) · Antioxidants · doi:10.3390/antiox10050661 · Cited by 103 · see citing works
You, J. H., Lee, J., & Roh, J. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.013 · Cited by 90 · see citing works
Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap
Halama, A., & Suhre, K. (2022) · Cancers · doi:10.3390/cancers14030553 · Cited by 92 · see citing works
Le, X. H., Lee, C. P., & Millar, A. H. (2021) · The Plant Cell · doi:10.1093/plcell/koab148 · Cited by 83 · see citing works
The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
Ruiz-Iglesias, A., & Mañes, S. (2021) · Cancers · doi:10.3390/cancers13071488 · Cited by 76 · see citing works
Cancer cell metabolism: Rewiring the mitochondrial hub
Oliveira, G. L., Coelho, A. R., Marques, R., & Oliveira, P. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166016 · Cited by 62 · see citing works
Pirola, C. J., Garaycoechea, M. E., Flichman, D. M., Castaño, G. O., & Sookoian, S. C. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13147 · Cited by 63 · see citing works
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
Longo, M., Paolini, E., Meroni, M., & Dongiovanni, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084173 · Cited by 61 · see citing works
Blocking mitochondrial pyruvate import in brown adipocytes induces energy wasting via lipid cycling
Veliova, M., Ferreira, C. M., Benador, I. Y., Jones, A. E., Mahdaviani, K., Brownstein, A. J., Desousa, B. R., Acín‐Pérez, R., Petcherski, A., Assali, E. A., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949634 · Cited by 51 · see citing works
Glutamine metabolic reprogramming in hepatocellular carcinoma
Ye, Y., Yu, B., Wang, H., & Yi, F. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1242059 · Cited by 47 · see citing works
Xu, R., Ritz, B. K., Wang, Y., Huang, J., Zhao, C., Gong, K., Liu, X., & Du, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011727 · Cited by 49 · see citing works
Sun, Y., Wang, X., Zhou, Y., Zhang, J., Cui, W., Wang, E., Du, J., Wei, B., & Xu, X. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141685 · Cited by 49 · see citing works
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer
Saggese, P., Sellitto, A., Martinez, C. A., Giurato, G., Nassa, G., Rizzo, F. M., Tarallo, R., & Scafoglio, C. (2020) · Cancers · doi:10.3390/cancers12123788 · Cited by 46 · see citing works
Luo, Y., Li, W., Ling, Z., Hu, Q., Fan, Z., Cheng, B., & Tao, X. (2020) · Cancer Medicine · doi:10.1002/cam4.2965 · Cited by 46 · see citing works
20,000 picometers under the OMM: diving into the vastness of mitochondrial metabolite transport
Cunningham, C. N., & Rutter, J. P. (2020) · EMBO Reports · doi:10.15252/embr.202050071 · Cited by 44 · see citing works
Sheldon, R. D., Ma, E. H., DeCamp, L. M., Williams, K. S., & Jones, R. G. (2021) · Nature Protocols · doi:10.1038/s41596-021-00586-2 · Cited by 43 · see citing works
Self-citationTavoulari, S., Sichrovsky, M., & Kunji, E. R. S. (2023) · Acta Physiologica · doi:10.1111/apha.14016 · Cited by 43 · see citing works
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 42 · see citing works
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 44 · see citing works
Mitochondrial pyruvate carrier function in health and disease across the lifespan
Buchanan, J., & Taylor, E. (2020) · Biomolecules · doi:10.3390/biom10081162 · Cited by 40 · see citing works
Self-citationWei, P., Bott, A. J., Cluntun, A. A., Morgan, J. T., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0117 · Cited by 38 · see citing works
Giafaglione, J. M., Crowell, P. D., Delcourt, A. M. L., Hashimoto, T., Ha, S. M., Atmakuri, A., Nunley, N. M., Dang, R. M. A., Tian, M., Diaz, J. A., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01274-x · Cited by 37 · see citing works
Key features of inhibitor binding to the human mitochondrial pyruvate carrier hetero-dimer
Tavoulari, S., Schirris, T. J. J., Mavridou, V., Thangaratnarajah, C., King, M. S., Jones, D. T. D., Ding, S., Fearnley, I. M., & Kunji, E. R. S. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101469 · Cited by 38 · see citing works
Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma
Ziki, R. A., & Colnot, S. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101077 · Cited by 35 · see citing works
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia
Dong, Q.-Z., Xiu, Y., Wang, Y., Hodgson, C., Borcherding, N., Jordan, C., Buchanan, J. L., Taylor, E., Wagner, B., Leidinger, M. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33861-1 · Cited by 31 · see citing works
Self-citationYiew, N. K. H., Vazquez, J. H., Martino, M. R., Kennon‐McGill, S., Price, J. R., Allard, F. D., Yee, E. U., Layman, A. J., James, L. P., McCommis, K. S., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101808 · Cited by 32 · see citing works
Golonka, R., & Vijay-Kumar, M. (2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.004 · Cited by 21 · see citing works
Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
Jiang, J., Zheng, Q., Zhu, W., Chen, X., Lu, H., Chen, D., Zhang, H., Shao, M., Zhou, L., & Zheng, S. (2020) · Aging · doi:10.18632/aging.103254 · Cited by 25 · see citing works
Ammar, N., Hildebrandt, M., Geismann, C., Röder, C., Gemoll, T., Sebens, S., Trauzold, A., & Schäfer, H. (2023) · Antioxidants · doi:10.3390/antiox12101818 · Cited by 27 · see citing works
The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer
Zhu, W., Lü, M., Wang, X., Xu, Z., Gao, C., & Qin, L. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.016 · Cited by 23 · see citing works
Li, Y., & Zeng, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1081952 · Cited by 22 · see citing works
Pravda, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i31.4263 · Cited by 23 · see citing works
Molecular basis of pyruvate transport and inhibition of the human mitochondrial pyruvate carrier
Sichrovsky, M., Lacabanne, D., Ruprecht, J. J., Rana, J. J., Stanik, K., Dionysopoulou, M., Sowton, A. P., King, M. S., Jones, S. A., Cooper, L. R., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw1489 · Cited by 21 · see citing works
Gopal, K., Abdualkader, A. M., Li, X., Greenwell, A. A., Karwi, Q. G., Altamimi, T., Saed, C. T., Uddin, G. M., Darwesh, A. M., Jamieson, K. L., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105375 · Cited by 20 · see citing works
Prohibitin‐1 Is a Dynamically Regulated Blood Protein With Cardioprotective Effects in Sepsis
Mattox, T. A., Psaltis, C. E., Weihbrecht, K., Robidoux, J., Kilburg-Basnyat, B. J., Murphy, M. P., Gowdy, K. M., & Anderson, E. J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019877 · Cited by 16 · see citing works
Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer
Fan, C., Kam, S., & Ramadori, P. (2021) · Cancers · doi:10.3390/cancers13205250 · Cited by 17 · see citing works
Dysbiotic Microbiome–Metabolome Axis in Childhood Obesity and Metabolic Syndrome
Salman, U., Dabdoub, S. M., Reyes, A., Sidahmed, A., Weber‐Gasparoni, K., Brown, R., Evans, I. A., Taylor, E. B., Mangalam, A. K., Kanner, L. A., et al. (2025) · Journal of Dental Research · doi:10.1177/00220345251336129 · Cited by 16 · see citing works
Self-citationNegreiros, R. S., Lander, N. M., Chiurillo, M. Á., Vercesi, A. E., & Docampo, R. (2021) · mBio · doi:10.1128/mbio.00540-21 · Cited by 15 · see citing works
Bai, Y., Zhang, F., Zhang, H., Xu, C., Wu, L., & Xia, C. (2020) · BioMed Research International · doi:10.1155/2020/9837543 · Cited by 16 · see citing works
Unraveling mitochondrial pyruvate dysfunction to mitigate hyperlactatemia and lethality in sepsis
Nuyttens, L., Heyerick, M., Heremans, G., Moens, E., Roes, M., Dender, C. V., Bus, L. D., Decruyenaere, J. M. A., Waele, J. J. D., Vandewalle, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116032 · Cited by 22 · see citing works
Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis
Ryuge, A., Kosugi, T., Maeda, K., Banno, R., Gou, Y., Zaitsu, K., Ito, T., Sato, Y., Hirayama, A., Tsubota, S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.142464 · Cited by 15 · see citing works
Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
Sun, M., Hines, N. G., Scerbo, D. A., Buchanan, J. L., Wu, C., Eyck, P. T., Zepeda‐Orozco, D., Taylor, E. B., & Jalal, D. I. (2022) · Antioxidants · doi:10.3390/antiox11071297 · Cited by 15 · see citing works
Self-citationBullert, A. J., Li, X., Chunyun, Z., Lee, K., Pulliam, C. F., Cagle, B. S., Doorn, J. A., Klingelhutz, A. J., Robertson, L. W., & Lehmler, H. (2023) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2023.104245 · Cited by 15 · see citing works
McCommis, K. S., & Finck, B. N. (2023) · Biomolecules · doi:10.3390/biom13020261 · Cited by 14 · see citing works
Insulin sensitizers in 2023: lessons learned and new avenues for investigation
Colca, J. R., Tanis, S. P., Kletzien, R. F., & Finck, B. N. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2263369 · Cited by 13 · see citing works
Findlay, S., Nair, R., Merrill, R. A., Kaiser, Z., Cajelot, A., Aryanpour, Z., Heath, J., St‐Louis, C., Papadopoli, D. J., Topisirović, I., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008345 · Cited by 13 · see citing works
Self-citationRauckhorst, A. J., Vasquez-Martinez, G., Andrade, G. M., Wen, H., Kim, J., Simoni, A. A., Robles-Planells, C., Mapuskar, K. A., Rastogi, P., Steinbach, E. J., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101849 · Cited by 13 · see citing works
Self-citationGe, H., Malsiu, F., Gao, Y., Losmanová, T., Blank, F., Ott, J. G., Medová, M., Peng, R., Deng, H., Dorn, P., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217353 · Cited by 11 · see citing works
Li, T., Zheng, W., & Kuang, H. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.113979 · Cited by 11 · see citing works
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK
Huang, C.-Y., Chung, Y.-H., Wu, S.-Y., Wang, H.-Y., Lin, C.-Y., Yang, T.-J., Fang, J., Hu, C., & Chang, Z.-F. (2024) · Communications Biology · doi:10.1038/s42003-024-06547-1 · Cited by 10 · see citing works
Activation of the integrated stress response in human hair follicles
Pye, D., Scholey, R., Ung, S., Dawson, M., Shahmalak, A., & Purba, T. S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303742 · Cited by 9 · see citing works
Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy
Zhao, Y., Zhang, X., An, M., Zhang, J., & Liu, Y. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2283829 · Cited by 8 · see citing works
Senecavirus A- and Non-Infected Cells at Early Stage of Infection: Comparative Metabolomic Profiles
Liu, F., Ni, B., & Wei, R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.736506 · Cited by 8 · see citing works
Kidney development at a glance: metabolic regulation of renal progenitor cells
Kurtzeborn, K., El-Dahr, S. S., Pakkasjärvi, N. A., Tortelote, G. G., & Kuure, S. (2024) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2024.11.009 · Cited by 7 · see citing works
Li, W., Cai, Z., Schindler, F., Brenner, M., Winter, C., Stiller, B., Heffeter, P., & Weckwerth, W. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c05570 · Cited by 7 · see citing works
Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma
Zhang, C., Liu, S., & Yang, M. J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i9.1887 · Cited by 7 · see citing works
Structural transport and inhibition mechanism of the mitochondrial pyruvate carrier
Lacabanne, D., Ruprecht, J. J., Sichrovsky, M., Forrest, L. R., Leone, V., Tavoulari, S., & Kunji, E. R. S. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.11.002 · Cited by 4 · see citing works
Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism
Li, Y., Yang, R.-R., Li, X., Liu, W.-W., Zhao, Y., Zu, M.-M., Gao, Y.-H., Huo, M.-Q., Jiang, Y., & Li, B. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05350-0 · Cited by 4 · see citing works
Yuan, Y., Song, J., & Wu, Q. (2022) · Medicine · doi:10.1097/md.0000000000031416 · Cited by 3 · see citing works
Kang, T., Usherwood, Y.-K., Reisz, J. A., Kamerkar, S. C., Culp‐Hill, R., Wilkins, O. M., Veríssimo, A. F., Kolling, F., Hung, A. M., Musial, S. C., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.187680 · Cited by 3 · see citing works
Gopal, K., Abdualkader, A. M., Li, X., Greenwell, A. A., Karwi, Q. G., Saed, C. T., Uddin, G. M., Darwesh, A. M., Jamieson, K. L., Altamimi, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.10.540277 · Cited by 3 · see citing works
Targeting Reductive Metabolic Shifts by T315I Mutation in BCR-ABL Myeloid Leukemia for TherapyPreprint
Huang, C.-Y., Chung, Y.-H., Wu, S.-Y., Wang, H.-Y., Lin, Z., Yang, T.-J., Feng, J.-M., Hu, C., & Chang, Z.-F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.22.485260 · Cited by 2 · see citing works
Yiew, N. K. H., Vazquez, J. H., Martino, M. R., Kennon‐McGill, S., Price, J. R., Allard, F. D., Yee, E. U., James, L. P., McCommis, K. S., Finck, B. N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.14.495517 · Cited by 2 · see citing works
Fluoride impairs vascular smooth muscle cells via disrupting amino acids metabolismPreprint
Li, Y., Yang, R.-R., Li, X.-Y., Liu, W.-W., Zhao, Y., Zu, M.-M., Gao, Y.-H., Huo, M.-Q., Jiang, Y., & Li, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4089224/v1 · Cited by 1 · see citing works
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J. T., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.26.457847
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3979182
Mitochondrial metabolism in progression of liver cancer
Bajpai, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98806-3.00003-9
Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma
Zhang, C., Liu, S., & Yang, M. J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i9.1886
Dougherty, M. C., Syed, H., Xu, L., Liu, S. J., Raleigh, D. R., Rauckhorst, A. J., Taylor, E. B., & Hansen, M. R. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf223
Self-citationZhu, W., Zhang, F., Qu, H., Li, N., Chen, X., & Tu, W. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2586736
Li, A., Dai, Y., Luo, Y., Liang, G., Gui, L., Hu, X., Li, X., Zhang, D., Zheng, W., Zhang, L., et al. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2026.159722
Das, S. R., Koman, I. E., & Nesher, E. (2026) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2026.08.003
Glutamine metabolism in health and disease
Zhao, J., Lin, Y., Gao, R., Gao, H., & Li, L. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02981-1
Liu, N., Zhou, D., Shi, M., Xiu, Y., Jiang, Y., Wang, Y., Moyano, G. A., McGuire, J. L., Iskender, A., Kilgore, M. D., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104446
- Authors
- Tompkins, S. C., Sheldon, R. D., Rauckhorst, A. J., Noterman, M. F., Solst, S. R., Buchanan, J. L., Mapuskar, K. A., Pewa, A. D., Gray, L. R., Oonthonpan, L., Sharma, A., Scerbo, D. A., Dupuy, A. J., Spitz, D. R., & Taylor, E. B.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Taylor, Eric B.
- ORCID
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 28
- Issue
- 10
- Pages
- 2608-2619.e6
- ISSN
- 2211-1247 (ISSN-L)
- PMC
- PMC6746334
- OpenAlex
- W2972083076
- Cited by
- 79
- References
- 57
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 7 · 2023: 14 · 2022: 14 · 2021: 14 · 2020: 17
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cell Reports (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Neurological Disorders and Stroke
- National Institute of General Medical Sciences
- American Diabetes Association
- National Heart, Lung, and Blood Institute
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mitochondrial pyruvate carrier, hepatocellular carcinoma, glutathione synthesis, glutamine metabolism, TCA cycle, metabolic competition, synthetic lethality, non-alcoholic fatty liver disease, glutathione depletion, liver-specific knockout
- MeSH terms
- Animals, Citric Acid Cycle, Glutamine, Glutathione, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Mice, Inbred C57BL, Mitochondria, Neoplasm Proteins, Organ Specificity, Apoptosis, Pyruvic Acid, Hepatocytes, Cell Line, Tumor, Transcriptome, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review